ScreenCancer approved for first round of Horizon 2020 programme

ScreenCancer has recently been approved for the first round of the Horizon 2020 programme. Horizon 2020 is the biggest EU Research and Innovation programme ever. The idea behind the initiative is to ensure European economic growth and job creation by supporting companies with great ideas who utilise world-class science and innovation. SceenCancer, together with the rest of the DeepX Health group, are proud to be a successful applicant for the programme and are excited to be recognised for our work.

December 15, 2020

Pharmacy Screening Demonstrates Great Efficiency and Potential for Cost Reductions

Read more

October 23, 2020

Primary Care Setting Pilot Launched with NHS

Read more

October 14, 2020

DeepX Health to Present at the 8th World Congress of Teledermatology, Imaging and Artificial Intelligence for Skin Diseases

Read more

September 30, 2020

ScreenCancer Awarded Support for Diagnostic Triage Algorithm-Project

Read more

January 8, 2020

DeepX Health to participate at the 7th Annual Dermatology Summit in San Francisco

Read more

December 13, 2019

DeepX Health to present at Digital Health World Congress in London

Read more

December 3, 2019

DeepX Health participate in the DxPx Conference

Read more